Apogee Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Apogee Therapeutics has filed a registration statement to offer an additional $80.5 million in common stock, including shares for underwriters' options, following its initial S-1 filing.
NASDAQ
Apogee Therapeutics plans to offer 6,000,000 shares of its common stock to fund clinical trials and research programs.